

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 6.60370567 |
| 2 | ribosomal small subunit biogenesis (GO:0042274) | 6.54995503 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 6.34637159 |
| 4 | translational termination (GO:0006415) | 6.29079272 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.07284963 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 5.95218451 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.95218451 |
| 8 | lens fiber cell development (GO:0070307) | 5.91078637 |
| 9 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.77549770 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 5.74846810 |
| 11 | protein targeting to ER (GO:0045047) | 5.67327232 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.42169007 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.39941665 |
| 14 | protein localization to endoplasmic reticulum (GO:0070972) | 5.39383461 |
| 15 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 5.37582047 |
| 16 | translational elongation (GO:0006414) | 5.27001563 |
| 17 | maturation of SSU-rRNA (GO:0030490) | 5.10755802 |
| 18 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 5.04704004 |
| 19 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 5.01317699 |
| 20 | cellular protein complex disassembly (GO:0043624) | 4.93809257 |
| 21 | viral life cycle (GO:0019058) | 4.92621254 |
| 22 | base-excision repair, AP site formation (GO:0006285) | 4.89350957 |
| 23 | respiratory electron transport chain (GO:0022904) | 4.70628528 |
| 24 | ribosomal large subunit biogenesis (GO:0042273) | 4.64879850 |
| 25 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 4.64504699 |
| 26 | UMP biosynthetic process (GO:0006222) | 4.64504699 |
| 27 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 4.64504699 |
| 28 | UMP metabolic process (GO:0046049) | 4.64504699 |
| 29 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.63873358 |
| 30 | electron transport chain (GO:0022900) | 4.59859424 |
| 31 | proteasome assembly (GO:0043248) | 4.55154106 |
| 32 | translational initiation (GO:0006413) | 4.49879465 |
| 33 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.47413192 |
| 34 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.47413192 |
| 35 | NADH dehydrogenase complex assembly (GO:0010257) | 4.47413192 |
| 36 | deoxyribonucleotide catabolic process (GO:0009264) | 4.45184681 |
| 37 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.42187935 |
| 38 | protein complex biogenesis (GO:0070271) | 4.35594458 |
| 39 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.25590973 |
| 40 | deoxyribose phosphate catabolic process (GO:0046386) | 4.25297845 |
| 41 | * translation (GO:0006412) | 4.25180837 |
| 42 | DNA deamination (GO:0045006) | 4.24419592 |
| 43 | chaperone-mediated protein transport (GO:0072321) | 4.24126834 |
| 44 | nucleobase biosynthetic process (GO:0046112) | 4.20451002 |
| 45 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.18583194 |
| 46 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.17251819 |
| 47 | protein complex disassembly (GO:0043241) | 4.14070332 |
| 48 | purine nucleotide salvage (GO:0032261) | 4.08103009 |
| 49 | termination of RNA polymerase III transcription (GO:0006386) | 4.02377483 |
| 50 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.02377483 |
| 51 | protein neddylation (GO:0045116) | 3.98003379 |
| 52 | establishment of integrated proviral latency (GO:0075713) | 3.95100639 |
| 53 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.95031268 |
| 54 | macromolecular complex disassembly (GO:0032984) | 3.93861819 |
| 55 | nucleotide salvage (GO:0043173) | 3.93616016 |
| 56 | GTP biosynthetic process (GO:0006183) | 3.91112842 |
| 57 | respiratory chain complex IV assembly (GO:0008535) | 3.89815578 |
| 58 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.84254246 |
| 59 | pyrimidine ribonucleoside biosynthetic process (GO:0046132) | 3.75216517 |
| 60 | dopamine transport (GO:0015872) | 3.74069043 |
| 61 | ncRNA 3-end processing (GO:0043628) | 3.68841302 |
| 62 | 7-methylguanosine mRNA capping (GO:0006370) | 3.68445690 |
| 63 | RNA capping (GO:0036260) | 3.64752587 |
| 64 | 7-methylguanosine RNA capping (GO:0009452) | 3.64752587 |
| 65 | positive regulation of isotype switching (GO:0045830) | 3.63901422 |
| 66 | pyrimidine nucleotide biosynthetic process (GO:0006221) | 3.62238832 |
| 67 | protein targeting to membrane (GO:0006612) | 3.61079820 |
| 68 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 3.60728452 |
| 69 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.57951773 |
| 70 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.57887794 |
| 71 | regulation of mitochondrial translation (GO:0070129) | 3.57091823 |
| 72 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.56150750 |
| 73 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.54327730 |
| 74 | pyrimidine ribonucleotide biosynthetic process (GO:0009220) | 3.50879916 |
| 75 | cellular component biogenesis (GO:0044085) | 3.49495011 |
| 76 | establishment of viral latency (GO:0019043) | 3.45458867 |
| 77 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.44626290 |
| 78 | pyrimidine nucleotide metabolic process (GO:0006220) | 3.44460390 |
| 79 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.44039998 |
| 80 | rRNA modification (GO:0000154) | 3.44002840 |
| 81 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.43915814 |
| 82 | cytochrome complex assembly (GO:0017004) | 3.39955022 |
| 83 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.38593172 |
| 84 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.37386043 |
| 85 | UTP biosynthetic process (GO:0006228) | 3.34665880 |
| 86 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.34428243 |
| 87 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.32323147 |
| 88 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.32004792 |
| 89 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.32004792 |
| 90 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.32004792 |
| 91 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.30949089 |
| 92 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.30949089 |
| 93 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.30824523 |
| 94 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.28921078 |
| 95 | negative regulation of ligase activity (GO:0051352) | 3.28921078 |
| 96 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.28630276 |
| 97 | mRNA catabolic process (GO:0006402) | 3.26673388 |
| 98 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.25498282 |
| 99 | nucleoside salvage (GO:0043174) | 3.25035682 |
| 100 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.24924293 |
| 101 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.23785022 |
| 102 | protein targeting to mitochondrion (GO:0006626) | 3.23482726 |
| 103 | platelet dense granule organization (GO:0060155) | 3.22293283 |
| 104 | CTP biosynthetic process (GO:0006241) | 3.21284287 |
| 105 | rRNA processing (GO:0006364) | 3.20926580 |
| 106 | pyrimidine-containing compound biosynthetic process (GO:0072528) | 3.20362530 |
| 107 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.18891921 |
| 108 | positive regulation of protein homodimerization activity (GO:0090073) | 3.18889943 |
| 109 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.18272001 |
| 110 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.18205716 |
| 111 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.18205716 |
| 112 | UTP metabolic process (GO:0046051) | 3.17555193 |
| 113 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.16001000 |
| 114 | cellular response to interferon-beta (GO:0035458) | 3.15742775 |
| 115 | establishment of protein localization to mitochondrion (GO:0072655) | 3.13100637 |
| 116 | leukotriene biosynthetic process (GO:0019370) | 3.12992497 |
| 117 | pyrimidine ribonucleotide metabolic process (GO:0009218) | 3.09402906 |
| 118 | deoxyribose phosphate metabolic process (GO:0019692) | 3.09259844 |
| 119 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.07112770 |
| 120 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.07087477 |
| 121 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.07011113 |
| 122 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.06468982 |
| 123 | formation of translation preinitiation complex (GO:0001731) | 3.06039300 |
| 124 | rRNA metabolic process (GO:0016072) | 3.05867755 |
| 125 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.02408115 |
| 126 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.01757374 |
| 127 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.01757374 |
| 128 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.00924912 |
| 129 | GDP-mannose metabolic process (GO:0019673) | 2.99364459 |
| 130 | termination of RNA polymerase I transcription (GO:0006363) | 2.98801333 |
| 131 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.98530299 |
| 132 | RNA catabolic process (GO:0006401) | 2.96950936 |
| 133 | GPI anchor biosynthetic process (GO:0006506) | 2.95943934 |
| 134 | pyrimidine nucleoside metabolic process (GO:0006213) | 2.95857686 |
| 135 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.95841193 |
| 136 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.94811741 |
| 137 | positive regulation of DNA recombination (GO:0045911) | 2.94288252 |
| 138 | peptidyl-histidine modification (GO:0018202) | 2.94107665 |
| 139 | oxidative phosphorylation (GO:0006119) | 2.93628965 |
| 140 | pseudouridine synthesis (GO:0001522) | 2.92658540 |
| 141 | ATP biosynthetic process (GO:0006754) | 2.92414224 |
| 142 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.91744364 |
| 143 | mannosylation (GO:0097502) | 2.91055683 |
| 144 | metallo-sulfur cluster assembly (GO:0031163) | 2.91033020 |
| 145 | iron-sulfur cluster assembly (GO:0016226) | 2.91033020 |
| 146 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.90843681 |
| 147 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.90356146 |
| 148 | spliceosomal snRNP assembly (GO:0000387) | 2.89711248 |
| 149 | rRNA methylation (GO:0031167) | 2.89711133 |
| 150 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.89586000 |
| 151 | CTP metabolic process (GO:0046036) | 2.89236433 |
| 152 | protein maturation by protein folding (GO:0022417) | 2.85671369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.48735551 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.74013224 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.31376969 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.20539343 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.02636455 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.77871573 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.70877108 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.59836921 |
| 9 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.56647330 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.52559190 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.45945981 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.42858253 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.20459281 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.11614265 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.99740944 |
| 16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.88723303 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.85991194 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.83606239 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.76706889 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.72823777 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.68867838 |
| 22 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.66215780 |
| 23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.52942839 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.50080381 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.44892678 |
| 26 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.35608464 |
| 27 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.31120419 |
| 28 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.28616318 |
| 29 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.22792735 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18395199 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.16959674 |
| 32 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.15683960 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.11576516 |
| 34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.09275236 |
| 35 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.01452184 |
| 36 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.01135847 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.97115168 |
| 38 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.91797924 |
| 39 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.87155714 |
| 40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.86260912 |
| 41 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.86193287 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85654380 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84618888 |
| 44 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.82310451 |
| 45 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.80650883 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.78367637 |
| 47 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.76911535 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.73985652 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73496313 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.72732479 |
| 51 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.70325183 |
| 52 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.70095633 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69571371 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.67806686 |
| 55 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.67486797 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65160191 |
| 57 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.64349659 |
| 58 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.60939930 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.57737788 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52362653 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51156979 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50607365 |
| 63 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50166197 |
| 64 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.50092991 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48951449 |
| 66 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.48510176 |
| 67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42595835 |
| 68 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42591378 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41304316 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40694272 |
| 71 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.40691388 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39761379 |
| 73 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.37512072 |
| 74 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.37221247 |
| 75 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34826754 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.31714970 |
| 77 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29178783 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29070806 |
| 79 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28149048 |
| 80 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.26707700 |
| 81 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.26429289 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.24676816 |
| 83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24231138 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22793900 |
| 85 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.22408218 |
| 86 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.21812831 |
| 87 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.21149399 |
| 88 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20939696 |
| 89 | * MAF_26560356_Chip-Seq_TH2_Human | 1.20582538 |
| 90 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.20185785 |
| 91 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20138546 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.19580600 |
| 93 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.18695426 |
| 94 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18665585 |
| 95 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.18276341 |
| 96 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18229540 |
| 97 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17999917 |
| 98 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17042379 |
| 99 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.16336158 |
| 100 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.15776888 |
| 101 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14459742 |
| 102 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14287690 |
| 103 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14157832 |
| 104 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.12422734 |
| 105 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.11248101 |
| 106 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.09774079 |
| 107 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09329457 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08894410 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08709439 |
| 110 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08635756 |
| 111 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08113622 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07961786 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.07355108 |
| 114 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.06202974 |
| 115 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05656343 |
| 116 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03010875 |
| 117 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02218466 |
| 118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01116825 |
| 119 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.01051758 |
| 120 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00857630 |
| 121 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.00686221 |
| 122 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.00383538 |
| 123 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99627966 |
| 124 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99565156 |
| 125 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.98916794 |
| 126 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96090108 |
| 127 | FUS_26573619_Chip-Seq_HEK293_Human | 0.95031375 |
| 128 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.93259814 |
| 129 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93202942 |
| 130 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.92872881 |
| 131 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90714054 |
| 132 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90408195 |
| 133 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.88844170 |
| 134 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88259222 |
| 135 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86609350 |
| 136 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.85316388 |
| 137 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.82167945 |
| 138 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81719763 |
| 139 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.78952454 |
| 140 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78093165 |
| 141 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.77760183 |
| 142 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77615657 |
| 143 | EWS_26573619_Chip-Seq_HEK293_Human | 0.76306064 |
| 144 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76276641 |
| 145 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.74008988 |
| 146 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.73861834 |
| 147 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.71255322 |
| 148 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.70655540 |
| 149 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.69855508 |
| 150 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69776982 |
| 151 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.68509496 |
| 152 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.65874561 |
| 153 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.64484987 |
| 154 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.63758015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.98593457 |
| 2 | MP0006082_CNS_inflammation | 4.60452832 |
| 3 | MP0001529_abnormal_vocalization | 3.28748548 |
| 4 | MP0001188_hyperpigmentation | 2.95393643 |
| 5 | MP0000858_altered_metastatic_potential | 2.94265119 |
| 6 | MP0001905_abnormal_dopamine_level | 2.79853429 |
| 7 | MP0006292_abnormal_olfactory_placode | 2.73845076 |
| 8 | MP0001873_stomach_inflammation | 2.51448143 |
| 9 | MP0004381_abnormal_hair_follicle | 2.35594445 |
| 10 | MP0002638_abnormal_pupillary_reflex | 2.31410996 |
| 11 | MP0008058_abnormal_DNA_repair | 2.29995781 |
| 12 | MP0005409_darkened_coat_color | 2.27787229 |
| 13 | MP0003880_abnormal_central_pattern | 2.23210921 |
| 14 | MP0003136_yellow_coat_color | 2.21773830 |
| 15 | MP0002132_abnormal_respiratory_system | 2.17375502 |
| 16 | MP0001986_abnormal_taste_sensitivity | 2.11537594 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.06610891 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.03259895 |
| 19 | MP0005408_hypopigmentation | 2.03217532 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 2.02475212 |
| 21 | MP0003693_abnormal_embryo_hatching | 2.01534895 |
| 22 | MP0005174_abnormal_tail_pigmentation | 2.00016895 |
| 23 | MP0000678_abnormal_parathyroid_gland | 1.94968037 |
| 24 | MP0008057_abnormal_DNA_replication | 1.94746973 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.94595950 |
| 26 | MP0005671_abnormal_response_to | 1.88379993 |
| 27 | MP0002163_abnormal_gland_morphology | 1.81941988 |
| 28 | MP0001835_abnormal_antigen_presentation | 1.78858259 |
| 29 | MP0002938_white_spotting | 1.78128388 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.75177999 |
| 31 | MP0002102_abnormal_ear_morphology | 1.75044739 |
| 32 | MP0000566_synostosis | 1.74320680 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.73614224 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.72456918 |
| 35 | MP0009278_abnormal_bone_marrow | 1.71143918 |
| 36 | MP0005379_endocrine/exocrine_gland_phen | 1.68458152 |
| 37 | MP0009785_altered_susceptibility_to | 1.65598980 |
| 38 | MP0002095_abnormal_skin_pigmentation | 1.64119675 |
| 39 | MP0005423_abnormal_somatic_nervous | 1.62719848 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.54893113 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.53753205 |
| 42 | MP0004957_abnormal_blastocyst_morpholog | 1.52984225 |
| 43 | MP0003186_abnormal_redox_activity | 1.52380862 |
| 44 | MP0004858_abnormal_nervous_system | 1.50735427 |
| 45 | MP0003786_premature_aging | 1.50690536 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.49751193 |
| 47 | MP0009697_abnormal_copulation | 1.49118604 |
| 48 | MP0004142_abnormal_muscle_tone | 1.48269624 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.44091505 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 1.44075342 |
| 51 | MP0008469_abnormal_protein_level | 1.41597491 |
| 52 | MP0003724_increased_susceptibility_to | 1.35362705 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.34359647 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.33767512 |
| 55 | MP0005171_absent_coat_pigmentation | 1.32627344 |
| 56 | MP0005084_abnormal_gallbladder_morpholo | 1.31713524 |
| 57 | MP0008932_abnormal_embryonic_tissue | 1.31689475 |
| 58 | MP0001663_abnormal_digestive_system | 1.31438418 |
| 59 | MP0000685_abnormal_immune_system | 1.30559356 |
| 60 | MP0010094_abnormal_chromosome_stability | 1.29720970 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.27761309 |
| 62 | MP0003718_maternal_effect | 1.27602181 |
| 63 | MP0004510_myositis | 1.26119814 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.24136834 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.23885626 |
| 66 | MP0008995_early_reproductive_senescence | 1.20048223 |
| 67 | MP0005025_abnormal_response_to | 1.19239478 |
| 68 | MP0002751_abnormal_autonomic_nervous | 1.18563016 |
| 69 | MP0003077_abnormal_cell_cycle | 1.18513016 |
| 70 | MP0008260_abnormal_autophagy | 1.17743635 |
| 71 | MP0001853_heart_inflammation | 1.17619911 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.16040968 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.13824788 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.13824788 |
| 75 | MP0002723_abnormal_immune_serum | 1.09661359 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 1.09549160 |
| 77 | MP0003303_peritoneal_inflammation | 1.08258281 |
| 78 | MP0008877_abnormal_DNA_methylation | 1.05863821 |
| 79 | MP0005330_cardiomyopathy | 1.05709284 |
| 80 | MP0008789_abnormal_olfactory_epithelium | 1.03615677 |
| 81 | MP0002139_abnormal_hepatobiliary_system | 1.03330468 |
| 82 | MP0003315_abnormal_perineum_morphology | 1.03304327 |
| 83 | MP0000343_altered_response_to | 1.01592460 |
| 84 | MP0002249_abnormal_larynx_morphology | 1.00562909 |
| 85 | MP0001800_abnormal_humoral_immune | 1.00326382 |
| 86 | MP0001727_abnormal_embryo_implantation | 1.00088358 |
| 87 | MP0005451_abnormal_body_composition | 0.99532132 |
| 88 | MP0009840_abnormal_foam_cell | 0.98477779 |
| 89 | MP0002420_abnormal_adaptive_immunity | 0.97923355 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.97245322 |
| 91 | MP0001819_abnormal_immune_cell | 0.96856611 |
| 92 | MP0000681_abnormal_thyroid_gland | 0.96215079 |
| 93 | MP0000049_abnormal_middle_ear | 0.95203812 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.94961751 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.92927957 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.91703884 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.90796020 |
| 98 | MP0002452_abnormal_antigen_presenting | 0.90647726 |
| 99 | MP0000750_abnormal_muscle_regeneration | 0.89127938 |
| 100 | MP0005645_abnormal_hypothalamus_physiol | 0.88797142 |
| 101 | MP0005666_abnormal_adipose_tissue | 0.88703479 |
| 102 | MP0000313_abnormal_cell_death | 0.87268030 |
| 103 | MP0002398_abnormal_bone_marrow | 0.87200239 |
| 104 | MP0000749_muscle_degeneration | 0.86975371 |
| 105 | MP0002396_abnormal_hematopoietic_system | 0.86786187 |
| 106 | MP0008007_abnormal_cellular_replicative | 0.82952869 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.82871171 |
| 108 | MP0003075_altered_response_to | 0.81095413 |
| 109 | MP0000716_abnormal_immune_system | 0.80991235 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.78567808 |
| 111 | MP0000689_abnormal_spleen_morphology | 0.78479955 |
| 112 | MP0002735_abnormal_chemical_nociception | 0.77869798 |
| 113 | MP0002419_abnormal_innate_immunity | 0.77681763 |
| 114 | MP0005501_abnormal_skin_physiology | 0.77385103 |
| 115 | MP0003111_abnormal_nucleus_morphology | 0.76776360 |
| 116 | MP0000759_abnormal_skeletal_muscle | 0.76303120 |
| 117 | MP0002736_abnormal_nociception_after | 0.76199602 |
| 118 | MP0008872_abnormal_physiological_respon | 0.75987315 |
| 119 | MP0001790_abnormal_immune_system | 0.75972616 |
| 120 | MP0005387_immune_system_phenotype | 0.75972616 |
| 121 | MP0001186_pigmentation_phenotype | 0.75041696 |
| 122 | MP0002722_abnormal_immune_system | 0.74771436 |
| 123 | MP0009764_decreased_sensitivity_to | 0.74584338 |
| 124 | MP0009053_abnormal_anal_canal | 0.74323759 |
| 125 | MP0002429_abnormal_blood_cell | 0.74303402 |
| 126 | MP0005166_decreased_susceptibility_to | 0.73507947 |
| 127 | MP0004133_heterotaxia | 0.73167961 |
| 128 | MP0002405_respiratory_system_inflammati | 0.71936770 |
| 129 | MP0003436_decreased_susceptibility_to | 0.71749060 |
| 130 | MP0004147_increased_porphyrin_level | 0.70834012 |
| 131 | MP0003646_muscle_fatigue | 0.70739655 |
| 132 | MP0001661_extended_life_span | 0.70698645 |
| 133 | MP0004742_abnormal_vestibular_system | 0.70298391 |
| 134 | MP0000003_abnormal_adipose_tissue | 0.70171924 |
| 135 | MP0003011_delayed_dark_adaptation | 0.69877140 |
| 136 | MP0000703_abnormal_thymus_morphology | 0.68866105 |
| 137 | MP0003122_maternal_imprinting | 0.68755675 |
| 138 | MP0004947_skin_inflammation | 0.68180043 |
| 139 | MP0000026_abnormal_inner_ear | 0.67814571 |
| 140 | MP0003806_abnormal_nucleotide_metabolis | 0.67487831 |
| 141 | MP0003941_abnormal_skin_development | 0.67331763 |
| 142 | MP0001764_abnormal_homeostasis | 0.65376760 |
| 143 | MP0005636_abnormal_mineral_homeostasis | 0.65350281 |
| 144 | MP0006072_abnormal_retinal_apoptosis | 0.65226444 |
| 145 | MP0000490_abnormal_crypts_of | 0.65163799 |
| 146 | MP0001968_abnormal_touch/_nociception | 0.65010908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nasal polyposis (HP:0100582) | 6.42968756 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.98899116 |
| 3 | Abnormality of the nasal mucosa (HP:0000433) | 5.65565887 |
| 4 | Mitochondrial inheritance (HP:0001427) | 5.38221658 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.26734872 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.17447179 |
| 7 | Reticulocytopenia (HP:0001896) | 4.89775726 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 4.86045945 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.75073167 |
| 10 | Hepatocellular necrosis (HP:0001404) | 4.70213455 |
| 11 | Acute encephalopathy (HP:0006846) | 4.62036762 |
| 12 | Thrombocytosis (HP:0001894) | 4.55458915 |
| 13 | Increased CSF lactate (HP:0002490) | 4.50330502 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 4.47271916 |
| 15 | 3-Methylglutaconic aciduria (HP:0003535) | 4.46513987 |
| 16 | Renal Fanconi syndrome (HP:0001994) | 4.17802132 |
| 17 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.14981375 |
| 18 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 4.10117752 |
| 19 | Hepatic necrosis (HP:0002605) | 4.07774263 |
| 20 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.99789980 |
| 21 | Lipid accumulation in hepatocytes (HP:0006561) | 3.77136042 |
| 22 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.66891813 |
| 23 | Zonular cataract (HP:0010920) | 3.66194820 |
| 24 | Pallor (HP:0000980) | 3.62436122 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.61310795 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.61310795 |
| 27 | Macrocytic anemia (HP:0001972) | 3.55122632 |
| 28 | Ragged-red muscle fibers (HP:0003200) | 3.54444764 |
| 29 | Exertional dyspnea (HP:0002875) | 3.45039572 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.41673029 |
| 31 | Exercise intolerance (HP:0003546) | 3.38025512 |
| 32 | Abnormality of the anterior horn cell (HP:0006802) | 3.30209612 |
| 33 | Degeneration of anterior horn cells (HP:0002398) | 3.30209612 |
| 34 | Increased serum lactate (HP:0002151) | 3.20839314 |
| 35 | Optic disc pallor (HP:0000543) | 3.10465304 |
| 36 | Diaphragmatic weakness (HP:0009113) | 3.10127165 |
| 37 | Stridor (HP:0010307) | 3.05778853 |
| 38 | Megaloblastic anemia (HP:0001889) | 3.04717204 |
| 39 | Increased intramyocellular lipid droplets (HP:0012240) | 3.02624042 |
| 40 | Cerebral edema (HP:0002181) | 3.01565612 |
| 41 | Lactic acidosis (HP:0003128) | 3.00318261 |
| 42 | Respiratory failure (HP:0002878) | 2.98734040 |
| 43 | Respiratory difficulties (HP:0002880) | 2.86825039 |
| 44 | Microvesicular hepatic steatosis (HP:0001414) | 2.86816307 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.84255569 |
| 46 | Type I transferrin isoform profile (HP:0003642) | 2.84137815 |
| 47 | Testicular atrophy (HP:0000029) | 2.81818971 |
| 48 | Leukodystrophy (HP:0002415) | 2.76096116 |
| 49 | Increased serum ferritin (HP:0003281) | 2.65613952 |
| 50 | Duplicated collecting system (HP:0000081) | 2.57515948 |
| 51 | Abnormality of renal resorption (HP:0011038) | 2.56839974 |
| 52 | Abnormality of glycolysis (HP:0004366) | 2.56422774 |
| 53 | Increased serum pyruvate (HP:0003542) | 2.56422774 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.54430732 |
| 55 | Obstructive lung disease (HP:0006536) | 2.54430732 |
| 56 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.51892765 |
| 57 | Aplastic anemia (HP:0001915) | 2.51023650 |
| 58 | Abnormality of the renal collecting system (HP:0004742) | 2.48996637 |
| 59 | Hypothermia (HP:0002045) | 2.48693996 |
| 60 | Vacuolated lymphocytes (HP:0001922) | 2.36916474 |
| 61 | Hypertensive crisis (HP:0100735) | 2.36784128 |
| 62 | Increased muscle lipid content (HP:0009058) | 2.33592438 |
| 63 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.31478256 |
| 64 | Delayed CNS myelination (HP:0002188) | 2.29866895 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.26098185 |
| 66 | Rhabdomyolysis (HP:0003201) | 2.19626691 |
| 67 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.16406006 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.16191046 |
| 69 | Parakeratosis (HP:0001036) | 2.15301787 |
| 70 | Broad distal phalanx of finger (HP:0009836) | 2.12910849 |
| 71 | Abnormal pupillary function (HP:0007686) | 2.12111309 |
| 72 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.11442112 |
| 73 | 11 pairs of ribs (HP:0000878) | 2.09884067 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09778765 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09778765 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09778765 |
| 77 | Multiple enchondromatosis (HP:0005701) | 2.08704851 |
| 78 | Unilateral renal agenesis (HP:0000122) | 2.07793880 |
| 79 | Erythema (HP:0010783) | 2.06764930 |
| 80 | Progressive muscle weakness (HP:0003323) | 2.03172620 |
| 81 | Myositis (HP:0100614) | 2.03105532 |
| 82 | Gout (HP:0001997) | 2.02304159 |
| 83 | Birth length less than 3rd percentile (HP:0003561) | 2.02003775 |
| 84 | Abnormality of secondary sexual hair (HP:0009888) | 2.01794609 |
| 85 | Abnormality of the axillary hair (HP:0100134) | 2.01794609 |
| 86 | Neoplasm of head and neck (HP:0012288) | 2.01380720 |
| 87 | Esophageal neoplasm (HP:0100751) | 2.01380720 |
| 88 | Chromsome breakage (HP:0040012) | 2.01122333 |
| 89 | Microretrognathia (HP:0000308) | 1.99537037 |
| 90 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98571891 |
| 91 | Purpura (HP:0000979) | 1.98068754 |
| 92 | Mediastinal lymphadenopathy (HP:0100721) | 1.97556899 |
| 93 | Recurrent bacterial skin infections (HP:0005406) | 1.97488801 |
| 94 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96109994 |
| 95 | Dicarboxylic aciduria (HP:0003215) | 1.96109994 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.94982977 |
| 97 | IgM deficiency (HP:0002850) | 1.94542115 |
| 98 | Cerebral hypomyelination (HP:0006808) | 1.94257934 |
| 99 | J-shaped sella turcica (HP:0002680) | 1.93523308 |
| 100 | Pancreatic fibrosis (HP:0100732) | 1.91786314 |
| 101 | Patchy hypopigmentation of hair (HP:0011365) | 1.90345356 |
| 102 | Abnormality of urine glucose concentration (HP:0011016) | 1.89316672 |
| 103 | Glycosuria (HP:0003076) | 1.89316672 |
| 104 | Athetosis (HP:0002305) | 1.89085543 |
| 105 | Emotional lability (HP:0000712) | 1.87792046 |
| 106 | Pancytopenia (HP:0001876) | 1.87650363 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 1.86050520 |
| 108 | Bulbar palsy (HP:0001283) | 1.84737398 |
| 109 | Premature graying of hair (HP:0002216) | 1.84364039 |
| 110 | X-linked dominant inheritance (HP:0001423) | 1.84184598 |
| 111 | Joint stiffness (HP:0001387) | 1.83453048 |
| 112 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.82625150 |
| 113 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.82625150 |
| 114 | True hermaphroditism (HP:0010459) | 1.82407867 |
| 115 | Type 2 muscle fiber atrophy (HP:0003554) | 1.79616865 |
| 116 | CNS demyelination (HP:0007305) | 1.78491170 |
| 117 | Rough bone trabeculation (HP:0100670) | 1.77673644 |
| 118 | Petechiae (HP:0000967) | 1.77479125 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 1.77207879 |
| 120 | Asplenia (HP:0001746) | 1.76784231 |
| 121 | Blindness (HP:0000618) | 1.76781695 |
| 122 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.75432299 |
| 123 | Dysphonia (HP:0001618) | 1.75036158 |
| 124 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.74995433 |
| 125 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.74813881 |
| 126 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.74813881 |
| 127 | Abnormal protein glycosylation (HP:0012346) | 1.74813881 |
| 128 | Abnormal glycosylation (HP:0012345) | 1.74813881 |
| 129 | Conical tooth (HP:0000698) | 1.74428936 |
| 130 | Medial flaring of the eyebrow (HP:0010747) | 1.74344368 |
| 131 | Abnormality of the preputium (HP:0100587) | 1.74049496 |
| 132 | Myopathic facies (HP:0002058) | 1.72671810 |
| 133 | Hyperthyroidism (HP:0000836) | 1.71812877 |
| 134 | Abnormal ciliary motility (HP:0012262) | 1.70376845 |
| 135 | Pancreatic cysts (HP:0001737) | 1.69808943 |
| 136 | Premature skin wrinkling (HP:0100678) | 1.69356396 |
| 137 | Prostate neoplasm (HP:0100787) | 1.69337455 |
| 138 | Abnormality of macrophages (HP:0004311) | 1.69238983 |
| 139 | Achilles tendon contracture (HP:0001771) | 1.69167694 |
| 140 | Absent thumb (HP:0009777) | 1.68783941 |
| 141 | Triphalangeal thumb (HP:0001199) | 1.68342291 |
| 142 | Renal tubular dysfunction (HP:0000124) | 1.68254048 |
| 143 | Vertebral compression fractures (HP:0002953) | 1.67599456 |
| 144 | Hyperphosphaturia (HP:0003109) | 1.66474417 |
| 145 | White forelock (HP:0002211) | 1.64689480 |
| 146 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.64222250 |
| 147 | Congenital, generalized hypertrichosis (HP:0004540) | 1.64145703 |
| 148 | Duplication of thumb phalanx (HP:0009942) | 1.63766137 |
| 149 | Abnormality of T cells (HP:0002843) | 1.63222961 |
| 150 | Abnormal trabecular bone morphology (HP:0100671) | 1.61588076 |
| 151 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.60697593 |
| 152 | Concave nail (HP:0001598) | 1.60229389 |
| 153 | Systemic lupus erythematosus (HP:0002725) | 1.59217445 |
| 154 | Reduced antithrombin III activity (HP:0001976) | 1.58861750 |
| 155 | Abnormality of the prostate (HP:0008775) | 1.58231242 |
| 156 | Carpal bone hypoplasia (HP:0001498) | 1.57697306 |
| 157 | Limb dystonia (HP:0002451) | 1.57137280 |
| 158 | Muscle fiber atrophy (HP:0100295) | 1.56765897 |
| 159 | Prolonged neonatal jaundice (HP:0006579) | 1.54819179 |
| 160 | Abnormal hair whorl (HP:0010721) | 1.53869240 |
| 161 | Depressed nasal ridge (HP:0000457) | 1.53728141 |
| 162 | IgG deficiency (HP:0004315) | 1.53069969 |
| 163 | Recurrent abscess formation (HP:0002722) | 1.50920955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 4.24576684 |
| 2 | NME2 | 3.84483918 |
| 3 | BUB1 | 3.44280930 |
| 4 | VRK2 | 2.86488948 |
| 5 | ARAF | 2.65043135 |
| 6 | NME1 | 2.37995359 |
| 7 | MAP3K12 | 2.35276911 |
| 8 | SMG1 | 2.35145015 |
| 9 | ITK | 2.29799374 |
| 10 | BMPR1B | 2.28586460 |
| 11 | SRPK1 | 2.28411575 |
| 12 | MST4 | 2.24767343 |
| 13 | VRK1 | 2.21475185 |
| 14 | CASK | 2.08073673 |
| 15 | TBK1 | 2.04428660 |
| 16 | EIF2AK3 | 1.96590406 |
| 17 | ADRBK2 | 1.88486325 |
| 18 | TNIK | 1.87839850 |
| 19 | PBK | 1.83644934 |
| 20 | IRAK3 | 1.80649877 |
| 21 | ERN1 | 1.79144125 |
| 22 | MAPKAPK5 | 1.73656689 |
| 23 | TRIB3 | 1.70480610 |
| 24 | TESK1 | 1.70107224 |
| 25 | ZAP70 | 1.68739377 |
| 26 | MUSK | 1.60406468 |
| 27 | ACVR1B | 1.52868528 |
| 28 | BLK | 1.51487049 |
| 29 | WEE1 | 1.50846444 |
| 30 | MYLK | 1.49443107 |
| 31 | IRAK4 | 1.49316463 |
| 32 | PRKG2 | 1.48935924 |
| 33 | MKNK1 | 1.48149522 |
| 34 | PLK4 | 1.47361719 |
| 35 | TXK | 1.40486474 |
| 36 | CDK19 | 1.39116800 |
| 37 | PIM2 | 1.35991520 |
| 38 | ZAK | 1.33817440 |
| 39 | TEC | 1.32853338 |
| 40 | LRRK2 | 1.32427362 |
| 41 | SCYL2 | 1.28590012 |
| 42 | GRK7 | 1.28306936 |
| 43 | CDK4 | 1.26554082 |
| 44 | ICK | 1.26149708 |
| 45 | CHEK2 | 1.22226824 |
| 46 | TSSK6 | 1.18568566 |
| 47 | MAP2K7 | 1.18546626 |
| 48 | KDR | 1.17055501 |
| 49 | EIF2AK2 | 1.16677580 |
| 50 | MAP2K3 | 1.15905456 |
| 51 | TESK2 | 1.15261369 |
| 52 | EIF2AK1 | 1.12398019 |
| 53 | PTK2B | 1.06691288 |
| 54 | RPS6KA5 | 1.06494549 |
| 55 | TLK1 | 1.04829993 |
| 56 | PIM1 | 1.02171780 |
| 57 | DAPK1 | 1.00749844 |
| 58 | BMPR2 | 1.00376932 |
| 59 | DYRK2 | 1.00358583 |
| 60 | PAK4 | 0.99403134 |
| 61 | YES1 | 0.95430301 |
| 62 | PRPF4B | 0.95131015 |
| 63 | GSK3A | 0.93609268 |
| 64 | BTK | 0.93253935 |
| 65 | IKBKB | 0.87230689 |
| 66 | MKNK2 | 0.87002318 |
| 67 | CDK8 | 0.84197154 |
| 68 | STK4 | 0.83742817 |
| 69 | SYK | 0.83653178 |
| 70 | NLK | 0.80843326 |
| 71 | OBSCN | 0.79408684 |
| 72 | CSNK1G3 | 0.77732335 |
| 73 | LYN | 0.76786260 |
| 74 | RPS6KB2 | 0.76524982 |
| 75 | MAPK13 | 0.76457534 |
| 76 | GRK1 | 0.73990470 |
| 77 | TTN | 0.73979249 |
| 78 | TAOK1 | 0.73971606 |
| 79 | KIT | 0.70796480 |
| 80 | CSNK2A1 | 0.70197654 |
| 81 | SIK3 | 0.69966018 |
| 82 | IKBKE | 0.69108296 |
| 83 | PNCK | 0.66870409 |
| 84 | TGFBR1 | 0.66840891 |
| 85 | CCNB1 | 0.66783757 |
| 86 | MAP3K14 | 0.65618995 |
| 87 | SIK1 | 0.65411210 |
| 88 | TYK2 | 0.64944427 |
| 89 | IRAK1 | 0.64129565 |
| 90 | BCKDK | 0.64118916 |
| 91 | MAP3K8 | 0.64053805 |
| 92 | MAP4K1 | 0.63492803 |
| 93 | ABL2 | 0.62255627 |
| 94 | BRAF | 0.61413094 |
| 95 | CSNK2A2 | 0.60558898 |
| 96 | MAP3K3 | 0.59864790 |
| 97 | MAPK7 | 0.59260534 |
| 98 | ATR | 0.59199381 |
| 99 | BCR | 0.58891691 |
| 100 | CAMK2B | 0.57043927 |
| 101 | CDC7 | 0.56429251 |
| 102 | UHMK1 | 0.56100728 |
| 103 | ILK | 0.55988920 |
| 104 | RIPK4 | 0.55967017 |
| 105 | DYRK3 | 0.55871082 |
| 106 | AKT2 | 0.52947277 |
| 107 | MAP3K13 | 0.52668402 |
| 108 | AURKA | 0.52602305 |
| 109 | TAOK2 | 0.52529022 |
| 110 | MAPK11 | 0.51238463 |
| 111 | PASK | 0.51183478 |
| 112 | RPS6KL1 | 0.50436792 |
| 113 | RPS6KC1 | 0.50436792 |
| 114 | LIMK1 | 0.49432294 |
| 115 | MOS | 0.49073600 |
| 116 | MAP3K11 | 0.48483622 |
| 117 | ADRBK1 | 0.48384135 |
| 118 | PLK1 | 0.48308491 |
| 119 | MAP2K2 | 0.46922900 |
| 120 | PAK1 | 0.46467774 |
| 121 | PDPK1 | 0.46363344 |
| 122 | MAP3K7 | 0.45862593 |
| 123 | CLK1 | 0.45702174 |
| 124 | EPHA2 | 0.45688748 |
| 125 | RPS6KA6 | 0.45330751 |
| 126 | CDK7 | 0.44978961 |
| 127 | AURKB | 0.44754789 |
| 128 | LCK | 0.44739298 |
| 129 | WNK3 | 0.42337552 |
| 130 | FES | 0.42100207 |
| 131 | GRK6 | 0.40833544 |
| 132 | MAPK4 | 0.40685620 |
| 133 | PDK2 | 0.40209504 |
| 134 | CSNK1A1L | 0.39872106 |
| 135 | BRSK2 | 0.39755605 |
| 136 | DAPK3 | 0.38632009 |
| 137 | MAPK15 | 0.38613152 |
| 138 | CSNK1G1 | 0.38499304 |
| 139 | PRKCD | 0.38458219 |
| 140 | CAMK2G | 0.38286282 |
| 141 | PRKCI | 0.37591458 |
| 142 | PLK3 | 0.36397748 |
| 143 | OXSR1 | 0.35722773 |
| 144 | PRKD2 | 0.35655960 |
| 145 | PIK3CG | 0.35214932 |
| 146 | NEK6 | 0.35157369 |
| 147 | CSNK1A1 | 0.35133184 |
| 148 | IRAK2 | 0.34239225 |
| 149 | EEF2K | 0.34132605 |
| 150 | PKN1 | 0.34041957 |
| 151 | MATK | 0.33664651 |
| 152 | RPS6KA4 | 0.32293951 |
| 153 | RPS6KA1 | 0.29470081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Ribosome_Homo sapiens_hsa03010 | 5.63965424 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.45680277 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.00501641 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.89284792 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.51787388 |
| 6 | Protein export_Homo sapiens_hsa03060 | 3.05398205 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.81225017 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.73914230 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.73752532 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.38462607 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.34576318 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.27210395 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.18749511 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 2.15549274 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.86991656 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.84479651 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.77242325 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.74725618 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.70869443 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.57819859 |
| 21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.40543906 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.40354909 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.39494055 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.38496334 |
| 25 | Purine metabolism_Homo sapiens_hsa00230 | 1.38456970 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.29741834 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29546324 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26399117 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.19255634 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 1.17332151 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15553666 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15394755 |
| 33 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15283168 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.13362580 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12993959 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12392693 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08126724 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07305177 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06797407 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.03865129 |
| 41 | RNA transport_Homo sapiens_hsa03013 | 1.00950048 |
| 42 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.98677850 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95735579 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92055894 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91397586 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85431065 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85311394 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85031858 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82831986 |
| 50 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81096382 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80588840 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77190318 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77149704 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.74175051 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 0.73070605 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71953170 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71271144 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.70594184 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69282447 |
| 60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.68413997 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.68293351 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67965092 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.66419127 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65062521 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.64953729 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63635389 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63285900 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63143212 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62036182 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60933459 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60339524 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59591266 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58253659 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56046026 |
| 75 | Cell cycle_Homo sapiens_hsa04110 | 0.54882679 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53438187 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53391151 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52905934 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52313413 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49350931 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48882343 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47596828 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44815799 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43134081 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.41478121 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41107844 |
| 87 | Apoptosis_Homo sapiens_hsa04210 | 0.39946298 |
| 88 | Nicotine addiction_Homo sapiens_hsa05033 | 0.38971784 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37189017 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.35937644 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35712323 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35256917 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34939099 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34211715 |
| 95 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.34170955 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34043802 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33143179 |
| 98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.32754102 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32467855 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31418550 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31195347 |
| 102 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30746913 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.29571976 |
| 104 | Measles_Homo sapiens_hsa05162 | 0.29402942 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28689407 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.27956884 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27717116 |
| 108 | Alcoholism_Homo sapiens_hsa05034 | 0.27574147 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27020820 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.26516293 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26157054 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25151977 |
| 113 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.24650792 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.24284334 |
| 115 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.23426183 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.22812773 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22811778 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22479524 |
| 119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.22304952 |
| 120 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.21131087 |
| 121 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20845605 |
| 122 | Tuberculosis_Homo sapiens_hsa05152 | 0.20754349 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.19562348 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.18690788 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17973211 |
| 126 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.17836047 |
| 127 | Legionellosis_Homo sapiens_hsa05134 | 0.17306314 |
| 128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.15965458 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.15906020 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15845978 |
| 131 | Taste transduction_Homo sapiens_hsa04742 | 0.15707530 |
| 132 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.14364571 |
| 133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.12545126 |
| 134 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.11761039 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.11335795 |

